Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yiru Long"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Herpes B virus is a biosafety level 4 pathogen and widespread in its natural host species, macaques. Although most infected monkeys show asymptomatic or mild symptoms, human infections with this virus can cause serious neurological symptoms or fatal
Externí odkaz:
https://doaj.org/article/afd72965ba004f28b1fba7ef22b71b04
Autor:
Yiru Long, Jianhua Sun, Tian-Zhang Song, Tingting Liu, Feng Tang, Xinxin Zhang, Longfei Ding, Yunqiu Miao, Weiliang Zhu, Xiaoyan Pan, Qi An, Mian Qin, Xiankun Tong, Xionghua Peng, Pan Yu, Peng Zhu, Jianqing Xu, Xiaoyan Zhang, Yachun Zhang, Datao Liu, Ben Chen, Huilin Chen, Leike Zhang, Gengfu Xiao, Jianping Zuo, Wei Tang, Ji Zhou, Heng Li, Zhijian Xu, Hong-Yi Zheng, Xin-Yan Long, Qiuping Qin, Yong Gan, Jin Ren, Wei Huang, Yong-Tang Zheng, Guangyi Jin, Likun Gong
Publikováno v:
Cell Discovery, Vol 8, Iss 1, Pp 1-16 (2022)
Abstract Safe, effective, and economical vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to achieve adequate herd immunity and end the pandemic. We constructed a novel SARS-CoV-2 vaccine, CoVac501, which is a
Externí odkaz:
https://doaj.org/article/3c59c092141d418c8f84164569078712
Autor:
Wei Huang, Ji Zhou, Jia Li, Yakun Wan, Chao Hu, Meng Liu, Pan Xu, Feng Tang, Jianhua Sun, Xiaolu Yu, Yiru Long, Binfan Chen, Yongliang Tong, Mengwen Shan, Xiaomin Jia, Henglei Lu, Runqiu Chen, Jin Ren, Guangyi Jin, Likun Gong
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Various tumors are insensitive to immune checkpoint blockade (ICB) therapy. Toll-like receptors (TLRs) establish the link between innate and adaptive immunity, which can assist T-cell activation and serve as promising targets for combinati
Externí odkaz:
https://doaj.org/article/9785092a1d2a49138eedb944273457b5
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Activin A, a critical member of the transforming growth factor-β (TGF-β) superfamily, is a pluripotent factor involved in allergies, autoimmune diseases, cancers and other diseases with immune disorder. Similar to its family member, TGF-β, activin
Externí odkaz:
https://doaj.org/article/167e9c0e036048e8a6115d0e3eb44fda
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
With programmed death 1/ligand 1 (PD-1/PD-L1) as the cornerstone, anti-PD antibodies have pioneered revolutionary immunotherapies for malignancies. But most patients struggled to respond to anti-PD owing to primary or acquired resistance or even hype
Externí odkaz:
https://doaj.org/article/7347ffca46734a8db5796dcc024cf182
Autor:
Yiru Long, Runqiu Chen, Xiaolu Yu, Yongliang Tong, Xionghua Peng, Fanglin Li, Chao Hu, Jianhua Sun, Likun Gong
Publikováno v:
Cancer Immunology Research. 11:241-260
CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6) is known to be a regulator of membranal programmed death ligand 1 (PD-L1) stability and a factor associated with malignancy progression, but the effects and mechanisms of CMTM6 on tum
Autor:
Likun Gong, Jianhua Sun, Chao Hu, Fanglin Li, Xionghua Peng, Yongliang Tong, Xiaolu Yu, Runqiu Chen, Yiru Long
Supplementary Table and Figures S1-S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa86d1c48ee9763f1a818a60256e337
https://doi.org/10.1158/2326-6066.22546319.v1
https://doi.org/10.1158/2326-6066.22546319.v1
Autor:
Likun Gong, Jianhua Sun, Chao Hu, Fanglin Li, Xionghua Peng, Yongliang Tong, Xiaolu Yu, Runqiu Chen, Yiru Long
CKLF-like MARVEL transmembrane domain-containing protein 6 (CMTM6) is known to be a regulator of membranal programmed death ligand 1 (PD-L1) stability and a factor associated with malignancy progression, but the effects and mechanisms of CMTM6 on tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d5d1431089a2d4591960f7363139315
https://doi.org/10.1158/2326-6066.c.6551144
https://doi.org/10.1158/2326-6066.c.6551144
Autor:
Yiru Long, Runqiu Chen, Xiaolu Yu, Yongliang Tong, Xionghua Peng, Fanglin Li, Chao Hu, Jianhua Sun, Likun Gong
CKLF-like MARVEL transmembrane domain-containing 6 (CMTM6) has been identified as a regulator of membranal programmed death ligand 1 (PD-L1) stability and a factor associated with malignancy progression, but the effects and mechanisms of CMTM6 on tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eaf4538cc4ce727986a7e3cb4f6dd43
https://doi.org/10.1101/2022.05.06.490847
https://doi.org/10.1101/2022.05.06.490847
Publikováno v:
SSRN Electronic Journal.